Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Arcellx, Inc. (ACLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.60+0.52 (+2.88%)
At close: 04:00PM EDT
18.55 -0.05 (-0.27%)
After hours: 05:40PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close18.08
Open17.95
Bid15.62 x 800
Ask18.98 x 800
Day's Range17.95 - 18.92
52 Week Range6.03 - 26.91
Volume79,846
Avg. Volume231,619
Market Cap814.431M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-15.50
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACLX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arcellx, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/24/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more
  • Simply Wall St.

    We're Hopeful That Arcellx (NASDAQ:ACLX) Will Use Its Cash Wisely

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

  • PR Newswire

    Arcellx Announces Appointment of Maryam Abdul-Kareem as General Counsel

    Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the appointment of Maryam Abdul-Kareem, J.D., as General Counsel. Ms. Abdul-Kareem brings extensive legal and business expertise in the biopharmaceutical industry, including serving in senior positions at Kinnate Biopharma and AstraZeneca. At Arcellx, she will oversee a broad spectrum of legal,

  • PR Newswire

    Arcellx Announces Closing of Upsized Public Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares

    Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the closing of its upsized public offering of 8,050,000 shares of common stock, which includes the full exercise by the underwriters of their option to purchase an additional 1,050,000 shares of common stock, at a price to the public of $16.00 per share. The aggregate gross proceeds raised in th

Advertisement
Advertisement